Rise Advisors LLC Has $55,000 Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Rise Advisors LLC trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 42.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 93 shares of the biotechnology company’s stock after selling 68 shares during the period. Rise Advisors LLC’s holdings in Axon Enterprise were worth $55,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in AXON. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 19.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after acquiring an additional 500 shares during the last quarter. CIBC Asset Management Inc boosted its holdings in Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new position in Axon Enterprise in the third quarter valued at $221,000. Sequoia Financial Advisors LLC increased its stake in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after buying an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC bought a new stake in Axon Enterprise during the 3rd quarter worth about $814,000. 79.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC raised their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $488.67.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded down $7.85 during trading on Tuesday, reaching $562.86. 489,046 shares of the stock were exchanged, compared to its average volume of 761,101. Axon Enterprise, Inc. has a 12 month low of $244.01 and a 12 month high of $698.67. The stock has a 50-day moving average price of $596.20 and a 200-day moving average price of $443.16. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a market cap of $42.92 billion, a PE ratio of 145.44, a PEG ratio of 14.19 and a beta of 1.04.

Insider Activity at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. The trade was a 3.67 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 51,545 shares of company stock worth $31,159,317 in the last ninety days. 6.10% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.